Carregant...
Evaluating measurable residual disease in acute myeloid leukemia
Mounting evidence indicates that the presence of measurable (“minimal”) residual disease (MRD), defined as posttherapy persistence of leukemic cells at levels below morphologic detection, is a strong, independent prognostic marker of increased risk of relapse and shorter survival in patients with ac...
Guardat en:
| Publicat a: | Blood Adv |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Hematology
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5998930/ https://ncbi.nlm.nih.gov/pubmed/29895626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018016378 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|